No. |
薬物名(臨床試験情報から抽出) |
DrugBank |
KEGG DRUG * |
KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 |
Coenzymeq10 |
- |
- |
- |
- |
2件: 5, 21 |
2 |
Cysteamine |
Cysteamine |
D03634, D03635 |
- |
- |
4件: 8, 19, 21, 299 |
3 |
Cysteamine bitartrate |
Cysteamine |
D03634, D03635 |
- |
- |
4件: 8, 19, 21, 299 |
4 |
Dexmedetomidine |
Dexmedetomidine |
D00514, D01205 |
3件: ADRA2A, ADRA2B, ADRA2C |
2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
11件: 2, 4, 6, 21, 34, 70, 113, 212, 215, 226, 280 |
5 |
Elamipretide |
Elamipretide |
D10925 |
- |
- |
2件: 21, 324 |
6 |
Epi-743 |
- |
- |
- |
- |
2件: 21, 156 |
7 |
Fluzone® |
- |
- |
- |
- |
1件: 21 |
8 |
Kh176 |
- |
- |
- |
- |
1件: 21 |
9 |
Kl1333 |
- |
- |
- |
- |
1件: 21 |
10 |
Low residue diet intervention |
- |
- |
- |
- |
1件: 21 |
11 |
Mtp-131 |
- |
- |
- |
- |
1件: 21 |
12 |
Propofol |
Propofol |
D00549 |
16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ |
7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
8件: 6, 21, 22, 34, 46, 84, 98, 296 |
13 |
Rg2133 (2',3',5'-tri-o-acetyluridine) |
Uridine triacetate |
D09985 |
- |
- |
1件: 21 |
14 |
Sevoflurane |
Sevoflurane |
D00547 |
- |
- |
5件: 6, 21, 22, 98, 296 |
15 |
Spp-004 |
- |
- |
- |
- |
1件: 21 |
16 |
Tri-o-acetyluridine |
Uridine triacetate |
D09985 |
- |
- |
1件: 21 |